All eyes are on those on the front lines seeking to develop and produce new drugs. There’s unprecedented pressure to offer both immediate treatments for those affected and long-term biotherapies and vaccines to prevent future epidemics.
Interview with Niranjan Kulkarni, Senior Director, Allan Bream, Process Specialist, and Grace Linton, Process Architect at CRB that originally appeared in Cell and Gene Therapy Insights, on how commercial biopharma experience is shaping cell and gene therapy facility design.
Building information modeling software improves efficiency.
Technology, like BIM, is changing more than just healthcare’s latest therapeutic modalities and pharmaceutical advances. It’s also disrupting the design and implementation of the facilities that create them.